Details of the Drug Reposition

General Information of This Drug (ID: DM2S8W3)

Drug Name
Sc Veltuzumab   DM2S8W3
Drug Type
Monoclonal antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Idiopathic thrombocytopenic purpura DISFKGJU 3B64.10 Phase 1 [1]
Rheumatoid arthritis DISTSB4J FA20 Phase 1 [1]
------------------------------------------------------------------------------------

References

1 Subcutaneous injections of low doses of humanized anti-CD20 veltuzumab: a phase I study in chronic lymphocytic leukemia. Leuk Lymphoma. 2015 Oct 19:1-9.